Bre-X shareholders approve poison pill

Shareholders of Bre-X Minerals (TSE) recently approved a shareholders’ rights plan, a stock split and a resolution to spin out the Sangihe and Sable properties in Indonesia.

Shareholders approved the resolutions at a special meeting in Calgary.

Bre-X’s common shares will begin trading on the split basis on May 22.

Shareholders will receive nine new shares for each share held, representing the additional shares to which they are entitled.

The shareholders’ rights plan was approved by vote of disinterested shareholders, and approval was granted to transfer the Sangihe and Sable copper-gold properties to a wholly owned subsidiary (subject to regulatory approval).

Meanwhile, Bresea Resources (ME), majority shareholder of Bre-X, completed a $29.4-million, private-placement financing. The proceeds will be used to fund Bresea’s ongoing exploration programs in Indonesia, and for working capital.

Bresea owns 23% of Bre-X, whose key asset is the Busang gold project in Indonesia. Later this year, Bre-X plans to sell a 25% stake in the multi-million-ounce gold deposit to a major company that would act as operator.

Print


 

Republish this article

Be the first to comment on "Bre-X shareholders approve poison pill"

Leave a comment

Your email address will not be published.


*


By continuing to browse you agree to our use of cookies. To learn more, click more information

Dear user, please be aware that we use cookies to help users navigate our website content and to help us understand how we can improve the user experience. If you have ideas for how we can improve our services, we’d love to hear from you. Click here to email us. By continuing to browse you agree to our use of cookies. Please see our Privacy & Cookie Usage Policy to learn more.

Close